XCNQ
CLSH
, Last price
CAD
Name
CLS Holdings USA Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CLS Holdings USA, Inc., a diversified cannabis enterprise established in 2014 and headquartered in Miami, Florida, focuses its operations in the United States on extracting and transforming cannabinoids. The company specializes in isolating cannabinoids from cannabis plants and converting them into a variety of concentrates, including oils, waxes, edibles, and shatters. Its comprehensive service and product portfolio includes: Supplying organic medical cannabis to licensed retailers. Providing recreational marijuana products to authorized distributors and retailers. Offering its own in-house derived extraction products, such as oils and waxes. Delivering specialized processing and extraction services for licensed medical cannabis cultivators. Distributing cannabis strains in the form of vegetative cuttings to licensed medical cannabis growers. Providing consulting expertise to various cannabis-related businesses, including cultivators, dispensaries, and laboratories. Performing toll processing services. The company markets its products under the well-known Oasis Cannabis and City Trees brand names, with its concentrates serving pharmaceutical and other purposes.
Key people
Jeffrey Irwin Binder
Chairman of the Board, Chief Executive Officer · since 2017
Gregg E Carlson
Chief Financial Officer · since 2019
Andrew Glashow
President, Chief Operating Officer · since 2019
Frank Koretsky
Director · since 2015
Legal address
C/O Paracorp Incorporated
318 North Carson Street
Suite 208
Carson City, NV 89701
US
318 North Carson Street
Suite 208
Carson City, NV 89701
US
Headquarters
11767 South Dixie Highway
Suite 115
Miami, FL 33115
US
Suite 115
Miami, FL 33115
US
Previous name
Adelt Design, Inc.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑05 | 2023‑05 | 2022‑05 | 2021‑05 | 2020‑05 | 2019‑05 | 2018‑05 | 2017‑05 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||